Delhi High Court Balances Trademark Protection and Artistic Freedom in Doctors Without Borders vs Jigra Film Dispute
Introduction
In an important decision that touches upon the intersection of intellectual property rights, freedom of expression in cinema, and the reputation of global humanitarian brands, the Delhi High Court has delivered a nuanced ruling in a case involving the world-renowned medical aid organisation Médecins Sans Frontières (Doctors Without Borders). The Court declined to completely restrain the exhibition of the film Jigra but directed the producers to add a specific acknowledgement clarifying that the use of the organisation’s name was not intended to harm its reputation. This judgment offers valuable insights into how courts handle claims of trademark infringement and brand disparagement when real-world marks appear in fictional cinematic works.
Factual and Procedural Background
Médecins Sans Frontières, an international humanitarian organisation known for providing medical assistance in crisis zones, has built immense goodwill over decades. It operates under the name “Doctors Without Borders” and holds several trademark registrations in India, including its recognition as a well-known mark. The organisation has been active in India since 1999, offering help in areas such as HIV treatment, tuberculosis, malnutrition, and disaster relief. Its work has earned global acclaim, including the Nobel Peace Prize.
The dispute arose when the film Jigra, produced by Dharma Productions and starring Alia Bhatt, was released in October 2024. In certain scenes, the lead characters disguise themselves as representatives of Doctors Without Borders to execute a fictional prison break and cross international borders illegally. The organisation viewed this portrayal as unauthorised use of its mark that could link its humanitarian image with criminal activity, potentially harming its reputation and donor confidence. After sending a legal notice that was rejected, the Plaintiff filed a suit seeking an interim injunction to stop further exhibition of those scenes.
Dispute
The central dispute was whether the use of the Plaintiff’s well-known mark in the film amounted to trademark infringement by taking unfair advantage of its reputation or causing detriment to its distinctive character. The Plaintiff argued that the depiction created a negative association, suggesting that its credentials could be misused for illegal purposes. The Defendants, including the production house and the lead actress, contended that the film was a fictional work, the reference was minor and contextual, and it did not disparage the organisation or cause any real harm. They emphasised artistic freedom and the presence of a disclaimer in the film.
Reasoning and Analysis of the Judge
Justice Tejas Karia carefully examined whether the Plaintiff had made out a prima facie case for interim relief. The Court acknowledged the strong reputation of the Plaintiff’s mark and its well-known status in India. It also accepted that the film, being a commercial venture, involved use “in the course of trade.” However, the Judge stressed that for infringement under the relevant provision of the Trade Marks Act, the Plaintiff needed to show that the use was without due cause and caused unfair advantage or detriment to the mark.
The Court discussed several important principles from earlier cases. It referred to ITC Ltd. v. Philip Morris Products SA to explain that unfair advantage cannot be presumed and must be clearly established. Similarly, reliance was placed on Bloomberg Finance LP v. Prafull Saklecha to highlight the need to show actual or likely change in consumer behaviour or dilution of the mark’s distinctive character. The Judge also considered Tata Sons Limited v. Greenpeace International, noting that contextual or denominative use in artistic works does not automatically amount to infringement or disparagement, especially when there is no direct attack on the brand’s reputation.
On the facts, the Court found that while the use was deliberate and not merely incidental, the Plaintiff had not produced sufficient evidence at this stage to prove actual unfair advantage or tangible harm such as loss of donations. The film had received certification from the Central Board of Film Certification, which added weight to the Defendants’ position. At the same time, the Judge recognised the potential for some impact on the mark’s reputation due to its association with illegal border crossing in the storyline.
Final Decision of the Court and Point of Law Settled
The Court ultimately did not grant a full injunction stopping the film’s exhibition. Instead, it directed the Defendants to display a clear acknowledgement at the beginning of the film stating that the use of the Plaintiff’s mark was not intended to cause any harm or detriment to its distinctive character or reputation. This direction was to be implemented within four weeks. The application was disposed of with these observations.
This judgment settles important points in simple terms: courts will protect famous humanitarian and charitable brands from misuse that could tarnish their image, but they will also respect artistic freedom in cinema. Minor or contextual references in fictional works may not always justify a complete ban, especially when no clear evidence of actual damage is shown. Instead, suitable disclaimers or acknowledgements can provide balanced relief. The ruling underscores that reputation-based claims require strong prima facie evidence of harm or unfair riding on goodwill before drastic orders like injunctions are passed.
Case Title:Medecine Sans Frontiers International Vs Dharma Production Pvt.Ltd. and Ors
Date of Order: 30.04.2026
Case Number: CS(COMM) 1134/2024
Neutral Citation: 2026:DHC:3670
Name of Court: High Court of Delhi
Name of Hon'ble Judge: Justice Tejas Karia
Disclaimer: Readers are advised not to treat this as substitute for legal advise as it may contain errors in perception, interpretation, and presentation
Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
Suggested SEO Titles for Legal Journal:
Delhi High Court Refuses to Ban Jigra Film But Directs Acknowledgement for Doctors Without Borders Trademark Use, Doctors Without Borders vs Dharma Productions Judgment on Trademark In Film, Delhi HC Balances IP Rights and Cinematic Freedom in MSF Trademark Case, Key Takeaways from Delhi High Court Ruling on Brand Name Use in Movies, Alia Bhatt Jigra Film Trademark Dispute Decision by Justice Tejas Karia
SEO Tags: Delhi High Court Trademark Judgment, Doctors Without Borders Trademark Case, Jigra Film IP Dispute, Trademark Infringement in Cinema, Well Known Mark Protection India, Artistic Freedom vs IP Rights, Dharma Productions Legal Case, Humanitarian Brand Reputation, Section 29 Trade Marks Act, Brand Disparagement in Delhi High Court Balances Trademark Rights and Artistic Freedom in Film Depicting Humanitarian Organisation’s Mark
Introduction
In an important decision concerning the intersection of trademark law, artistic expression, and reputational concerns, the Delhi High Court addressed whether a popular Bollywood film could use the name and mark of a globally renowned humanitarian organisation without permission. The ruling provides clarity on when such use amounts to infringement or disparagement and how courts can protect well-known marks while respecting creative freedom in cinema.
Factual and Procedural Background
Médecins Sans Frontières International (MSF), popularly known as Doctors Without Borders, is an international humanitarian medical aid organisation that provides emergency medical assistance in conflict zones, disasters, and areas with limited healthcare access. The organisation has operated in India for many years and enjoys strong reputation and goodwill, supported by prestigious awards including the Nobel Peace Prize. Its marks are registered in India and have been declared well-known.
The defendants, including production house Dharma Productions and actress Alia Bhatt, released the film Jigra in October 2024. In certain scenes, the film’s characters disguise themselves as representatives of MSF (referred to as “Doctors Without Borders”) to execute a fictional prison break and cross international borders. MSF objected to this portrayal, claiming it tarnished its reputation by associating the organisation with illegal activities. After the defendants refused to remove the scenes, MSF filed a suit and sought an interim injunction to restrain further exhibition of those portions.
Dispute
The core dispute revolved around whether the defendants’ use of MSF’s well-known mark in the film constituted trademark infringement and disparagement. MSF argued that the depiction misused its reputation for border access to depict criminal acts, causing harm to its distinctive character and goodwill, especially among donors and the public. The defendants contended that the use was minimal, fictional, contextual to the story, protected by artistic freedom, and did not cause any actual damage or confusion. They maintained it was fair referential use in a creative work and not intended to ride on or harm the mark.
Reasoning and Analysis of the Judge
Justice Tejas Karia examined the matter under Section 29(4) of the Trade Marks Act, which protects well-known marks from uses that take unfair advantage or are detrimental to their distinctive character or repute. The judge acknowledged the plaintiff’s strong reputation and the commercial nature of the film but noted that the use was limited and served a narrative purpose in a fictional story.
The Court discussed relevant precedents. It referred to ITC Ltd. v. Philip Morris Products SA (2010 SCC OnLine Del 27) on the need to prove unfair advantage as a matter of fact rather than presumption. The judge also considered Bloomberg Finance LP v. Prafull Saklecha (2013 SCC OnLine Del 4159) and principles from foreign cases on artistic works, emphasizing that mere referential or contextual use in fiction does not automatically amount to infringement or disparagement.
On disparagement, the Court applied the test of how a reasonable viewer would perceive the content, finding no direct attack on MSF’s integrity. While the portrayal linked the mark to illegal border crossing in fiction, the judge held that this did not sufficiently prove dilution or tarnishment at the interim stage, especially given the Central Board of Film Certification’s approval. The Court stressed balancing intellectual property rights with freedom of expression under Article 19(1)(a) of the Constitution, subject to reasonable restrictions.
Final Decision of the Court and Point of Law Settled
The Court declined to grant a full injunction restraining the exhibition of the film. However, recognising potential detriment to the mark’s reputation, it directed the defendants to display a clear acknowledgment at the beginning of the film stating that the use of MSF’s mark is fictional and not intended to harm or associate with the organisation’s real activities. This was to be done within four weeks.
This judgment settles that in cases involving use of well-known marks in creative works like films, courts will not readily restrain artistic expression unless there is clear evidence of unfair advantage, actual detriment, or misleading association. It underscores that contextual, limited, and fictional use may be permissible with appropriate disclaimers to protect reputation, thereby striking a practical balance between trademark protection and cinematic freedom.
Case Details
Title: Medecins Sans Frontieres International versus Dharma Productions Private Limited and Ors.
Date of Order: 30 April 2026
Case Number: CS(COMM) 1134/2024
Neutral Citation: Not Available
Name of Court: High Court of Delhi
Name of Hon’ble Judge: Justice Tejas Karia
Disclaimer: Readers are advised not to treat this as substitute for legal advise as it may contain errors in perception, interpretation, and presentation.
Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
Suggested SEO Titles for Legal Journal:
Delhi High Court Refuses Injunction Against Film Using Doctors Without Borders Mark, MSF vs Dharma Productions Trademark Dispute Judgment, Delhi High Court Balances Trademark Rights and Artistic Freedom in Cinema, Well Known Mark Protection in Bollywood Films Ruling, Medecins Sans Frontieres Trademark Case Analysis
SEO Tags: Delhi High Court trademark judgment, Doctors Without Borders mark, MSF trademark infringement, film trademark dispute India, artistic freedom trademark law, well known mark dilution, Dharma Productions Jigra case, Justice Tejas Karia IP ruling, celebrity trademark litigation, AdvocateAjayAmitabhSuman, IPAdjutor
Headnote: Delhi High Court declines full injunction on film using humanitarian organisation’s well-known mark but directs display of disclaimer to prevent reputational harm, balancing trademark protection with creative expression in cinematographic works.
=====
Delhi High Court Refuses Injunction but Directs Disclaimer in Film’s Use of ‘Doctors Without Borders’ MarkCase Title: Medecins Sans Frontieres International versus Dharma Productions Private Limited and Ors.
Case Number: CS(COMM) 1134/2024
Date of Judgment: 30 April 2026
Court: High Court of Delhi
Judge: Hon’ble Mr. Justice Tejas Karia
Facts & Dispute:
Médecins Sans Frontières (MSF), internationally known as Doctors Without Borders, is a renowned humanitarian medical aid organisation with registered and well-known trademarks in India. The organisation objected to the use of its mark in the Bollywood film Jigra (produced by Dharma Productions and starring Alia Bhatt), where characters disguise themselves as MSF representatives to execute a fictional prison break and cross international borders. MSF claimed the portrayal tarnished its reputation by associating it with illegal activities and sought an interim injunction to restrain exhibition of the relevant scenes.
Reasoning of the Court:
Justice Tejas Karia held that while MSF has strong reputation and the film’s use was commercial in nature, the reference was limited, contextual, and part of a fictional narrative. The Court found no sufficient prima facie evidence of unfair advantage or actual detriment/dilution at the interim stage. It emphasised artistic freedom in cinema and noted the film’s certification by the Central Board of Film Certification. Precedents on trademark dilution and disparagement in creative works were considered, with the Court stressing that mere referential use in fiction does not automatically amount to infringement.
Decision:
The Court declined to grant a full injunction restraining the film’s exhibition. However, to balance equities and protect MSF’s reputation, it directed the defendants to display a suitable acknowledgment/disclaimer at the beginning of the film clarifying that the use of the mark is fictional and not intended to harm or associate with the plaintiff’s real activities. The direction was to be complied with within four weeks.
Disclaimer: Donot treat this as substitute for legal advise as it may contain subjective errors.
Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
#DelhiHighCourt, #TrademarkInfringement, #WellKnownMark, #DoctorsWithoutBorders, #FilmTrademarkDispute, #ArtisticFreedom, #MSFTrademark, #JigraMovieCase, #IPLitigation, #BollywoodIP, #TrademarkDilution, #IPUpdate, #AdvocateAjayAmitabhSuman, #IPAdjutor
=====
